Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of an unspecified antitumor agent (Japan)
jRCT2080222470Phase 1Completed
- Start
- Apr 2014
- Countries
- 1
01
Overview
Phase 1 trial in cancer. Started Apr 2014; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222470.